Elanco director defers fees into 584 stock units

Anand Kapila K reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Anand Kapila K reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health director K. Anand reported receiving 584.1121 Deferred Stock Units on June 30, 2026. These units were issued at an implied price of $24.61 per unit by deferring her director cash retainer into the company’s Directors’ Deferral Plan.

Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock and will be settled in stock when she leaves the Board. Following this compensation-related award, Anand holds a total of 10,079.5639 Deferred Stock Units directly.

Insider Trade Summary

Grant/Award: 584.1121 shares

Grant/Award 1 txn

Insider Anand Kapila K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	584.1121	$24.61	$14K

Holdings After Transaction: Deferred Stock Units — 10,079.5639 contracts (Direct)

Footnotes (3)

1. F1. Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
2. F2. The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
3. F3. The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on June 30, 2026.

Key Figures

Deferred Stock Units granted: 584.1121 units Implied grant price: $24.61 per unit Total Deferred Stock Units after award: 10,079.5639 units +1 more

4 metrics

Deferred Stock Units granted 584.1121 units Director fee deferral on June 30, 2026

Implied grant price $24.61 per unit Closing price of Elanco common stock on June 30, 2026

Total Deferred Stock Units after award 10,079.5639 units Holdings following June 30, 2026 grant

Underlying security 584.1121 shares Common stock underlying the new Deferred Stock Units

Key Terms

Deferred Stock Units, Directors' Deferral Plan, Elanco Deferred Stock Account, separation of service

4 terms

Deferred Stock Units financial

"Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Directors' Deferral Plan financial

"Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan")."

Elanco Deferred Stock Account financial

"such deferred fees were credited to the Elanco Deferred Stock Account under the Plan."

separation of service financial

"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elanco (ELAN) director K. Anand report in this Form 4?

K. Anand reported receiving 584.1121 Deferred Stock Units as director compensation. The units result from deferring her cash retainer into Elanco’s Directors’ Deferral Plan and are economically equivalent to common shares, increasing her total deferred holdings to 10,079.5639 units.

How were the 584.1121 Deferred Stock Units for Elanco (ELAN) calculated?

The 584.1121 Deferred Stock Units equal Anand’s deferred cash compensation divided by Elanco’s $24.61 closing share price on June 30, 2026. This converts her director cash retainer into stock-based units under the company’s Directors’ Deferral Plan as an alternative form of compensation.

When will Elanco (ELAN) settle K. Anand’s Deferred Stock Units in shares?

Elanco will settle K. Anand’s Deferred Stock Units in stock when she separates from the Board. Under the Directors’ Deferral Plan, the units remain as bookkeeping entries until her service ends, at which point they convert into shares of Elanco common stock.

Does this Elanco (ELAN) Form 4 show an open-market stock purchase or sale?

The Form 4 shows a grant/award acquisition, not an open-market trade. The 584.1121 Deferred Stock Units reflect director fees voluntarily deferred into stock units, rather than buying or selling Elanco shares in the market, and are classified as derivative securities.

What is K. Anand’s total Deferred Stock Unit position in Elanco (ELAN) after this filing?

After this award, K. Anand holds 10,079.5639 Deferred Stock Units directly. Each unit is the economic equivalent of one Elanco common share and represents deferred director compensation that will be settled in stock upon her separation from the Board of Directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:49 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anand Kapila K

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units(1)(2)	(3)	06/30/2026		A		584.1121		(1)	(1)	Common Stock	584.1121	$24.61(2)(3)	10,079.5639	D

Explanation of Responses:

1. Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

2. The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

3. The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on June 30, 2026.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Kapila K. Anand	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)